These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3140476)

  • 61. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of flow cytometry with static densitometry in papillary thyroid carcinoma.
    Cusick EL; MacIntosh CA; Krukowski ZH; Ewen SW; Matheson NA
    Br J Surg; 1990 Aug; 77(8):913-6. PubMed ID: 2393818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA cytophotometry in adrenocortical tumours: a clinicomorphological study of 66 cases.
    Padberg BC; Lauritzen I; Achilles E; Holl K; Bressel M; Klöppel G; Dralle H; Schröder S
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):167-70. PubMed ID: 1926757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nuclear DNA content and survival in medullary thyroid carcinoma. Swedish Medullary Thyroid Cancer Study Group.
    Ekman ET; Bergholm U; Bäckdahl M; Adami HO; Bergström R; Grimelius L; Auer G
    Cancer; 1990 Feb; 65(3):511-7. PubMed ID: 2297642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nuclear DNA analysis: DNA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma.
    al-Abadi H; Nagel R
    Eur Urol; 1992; 22(4):303-10. PubMed ID: 1490508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
    McLeod MK
    Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study.
    Wallin G; Bäckdahl M; Tallroth-Ekman E; Lundell G; Auer G; Löwhagen T
    Eur J Surg Oncol; 1989 Feb; 15(1):43-8. PubMed ID: 2465188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
    Wang SL; Li SH; Chen WT; Chai CY
    APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selective treatment of differentiated thyroid carcinoma.
    Gemsenjäger E; Heitz PU; Martina B
    World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A flow cytometric DNA analysis of medullary thyroid carcinoma.
    Tangen KO; Lindmo T; Sobrinho-Simóes M; Johannessen JV
    Am J Clin Pathol; 1983 Feb; 79(2):172-7. PubMed ID: 6823901
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
    Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
    Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytophotometric DNA measurements in medullary thyroid carcinoma.
    Galera-Davidson H; González-Cámpora R; Mora-Marín JA; Matilla-Vincente A; Dytch HE; Bartels PH; Lerma-Puertas E; Andrada-Becerra E; Bibbo M
    Cancer; 1990 May; 65(10):2255-60. PubMed ID: 2346910
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Iodine deficiency a persisting problem: assessment of iodine nutrition and evaluation of thyroid nodular pathology in Portugal.
    Santos JE; Freitas M; Fonseca CP; Castilho P; Carreira IM; Rombeau JL; Branco MC
    J Endocrinol Invest; 2017 Feb; 40(2):185-191. PubMed ID: 27619914
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA cytophotometry of acinic cell carcinoma and its relation to prognosis.
    Gustafsson H; Lindholm C; Carlsöö B
    Acta Otolaryngol; 1987; 104(3-4):370-6. PubMed ID: 3673565
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical significance of nuclear DNA content in human gastric tumors. A static cytometry study in 87 cases].
    Matturri L; Biondo B; Lavezzi AM
    Minerva Chir; 1991 Jun; 46(12):653-60. PubMed ID: 1961588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.
    Gilliland FD; Hunt WC; Morris DM; Key CR
    Cancer; 1997 Feb; 79(3):564-73. PubMed ID: 9028369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aggressive behaviour of solid arrangement pattern in differentiated papillary carcinoma of thyroid.
    Basu S; Nair N; Borges AM
    J Assoc Physicians India; 2003 Apr; 51():408-11. PubMed ID: 12723661
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone.
    Antal I; Sápi Z; Szendröi M
    Int Orthop; 1999; 23(6):315-9. PubMed ID: 10741513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.